Clinical Trial Update: Clinical Study of Smoke-Break Liquid Cigarettes [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating Smoke-Break Liquid Cigarettes by Smoke-Break, Inc. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Smoke-Break Liquid Cigarettes

Snippet

Sponsor: Smoke-Break, Inc. | Conditions: Smoking | Phase 2 | Status: COMPLETED